A hierarchical classification is proposed as follows: AML with mutated TP53 precedes AML with myelodysplasia-related gene mutations which, in turn, takes precedence over AML with myelodysplasia-related cytogenetic abnormalities [47]. The gene discussed is TP53; the disease is acute myeloid leukemia.